Mitochondrial Cardiomyopathies
- PMID: 27504452
- PMCID: PMC4958622
- DOI: 10.3389/fcvm.2016.00025
Mitochondrial Cardiomyopathies
Abstract
Mitochondria are found in all nucleated human cells and perform various essential functions, including the generation of cellular energy. Mitochondria are under dual genome control. Only a small fraction of their proteins are encoded by mitochondrial DNA (mtDNA), whereas more than 99% of them are encoded by nuclear DNA (nDNA). Mutations in mtDNA or mitochondria-related nDNA genes result in mitochondrial dysfunction leading to insufficient energy production required to meet the needs for various organs, particularly those with high energy requirements, including the central nervous system, skeletal and cardiac muscles, kidneys, liver, and endocrine system. Because cardiac muscles are one of the high energy demanding tissues, cardiac involvement occurs in mitochondrial diseases with cardiomyopathies being one of the most frequent cardiac manifestations found in these disorders. Cardiomyopathy is estimated to occur in 20-40% of children with mitochondrial diseases. Mitochondrial cardiomyopathies can vary in severity from asymptomatic status to severe manifestations including heart failure, arrhythmias, and sudden cardiac death. Hypertrophic cardiomyopathy is the most common type; however, mitochondrial cardiomyopathies might also present as dilated, restrictive, left ventricular non-compaction, and histiocytoid cardiomyopathies. Cardiomyopathies are frequent manifestations of mitochondrial diseases associated with defects in electron transport chain complexes subunits and their assembly factors, mitochondrial transfer RNAs, ribosomal RNAs, ribosomal proteins, translation factors, mtDNA maintenance, and coenzyme Q10 synthesis. Other mitochondrial diseases with cardiomyopathies include Barth syndrome, Sengers syndrome, TMEM70-related mitochondrial complex V deficiency, and Friedreich ataxia.
Keywords: Barth syndrome; Friedreich ataxia; dilated cardiomyopathy; histiocytoid cardiomyopathies; hypertrophic cardiomyopathy; non-compaction cardiomyopathy; restrictive cardiomyopathy.
Figures
Similar articles
-
Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies.Biochim Biophys Acta Mol Basis Dis. 2020 Aug 1;1866(8):165803. doi: 10.1016/j.bbadis.2020.165803. Epub 2020 Apr 27. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32348916 Review.
-
Progress in Molecular Genetic Study of Mitochondrial Cardiomyopathy.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):438-444. doi: 10.3881/j.issn.1000-503X.2017.03.024. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017. PMID: 28695818 Review.
-
Mitochondrial Mutations in Cardiac Disorders.Adv Exp Med Biol. 2017;982:81-111. doi: 10.1007/978-3-319-55330-6_5. Adv Exp Med Biol. 2017. PMID: 28551783 Review.
-
Mitochondrial cytopathies.Cell Calcium. 2016 Sep;60(3):199-206. doi: 10.1016/j.ceca.2016.03.003. Epub 2016 Mar 4. Cell Calcium. 2016. PMID: 26996063 Review.
-
Review: Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation.Ann Clin Lab Sci. 2003 Fall;33(4):371-95. Ann Clin Lab Sci. 2003. PMID: 14584751 Review.
Cited by
-
lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.Front Med. 2024 Jun;18(3):484-498. doi: 10.1007/s11684-023-1036-4. Epub 2024 May 14. Front Med. 2024. PMID: 38743133
-
Echocardiographic manifestations of mitochondrial disease with GTPBP3 gene mutations: A case report.Medicine (Baltimore). 2024 May 3;103(18):e37847. doi: 10.1097/MD.0000000000037847. Medicine (Baltimore). 2024. PMID: 38701254 Free PMC article.
-
The Cardiometabolic Impact of Rebaudioside A Exposure during the Reproductive Stage.Biology (Basel). 2024 Mar 2;13(3):163. doi: 10.3390/biology13030163. Biology (Basel). 2024. PMID: 38534433 Free PMC article.
-
Exploring mitochondrial biomarkers for Friedreich's ataxia: a multifaceted approach.J Neurol. 2024 Jun;271(6):3439-3454. doi: 10.1007/s00415-024-12223-5. Epub 2024 Mar 23. J Neurol. 2024. PMID: 38520521 Free PMC article.
-
Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy.Exp Biol Med (Maywood). 2023 Nov;248(22):2062-2071. doi: 10.1177/15353702231220658. Exp Biol Med (Maywood). 2023. PMID: 38235691 Review.
References
-
- Gilbert-Barness E. Review: metabolic cardiomyopathy and conduction system defects in children. Ann Clin Lab Sci (2004) 34:15–34. - PubMed
-
- Chinnery PF. Mitochondrial disorders overview. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, et al., editors. GeneReviews(®). Seattle, WA: University of Washington Seattle; (2014).
-
- Munnich A, Rötig A, Rio M. Defects of the respiratory chain. Inborn Metabolic Diseases Diagnosis and Treatment. Berlin: Springer; (2012). p. 223–38.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources